期刊文献+

肿瘤化疗多药耐药研究新进展 被引量:7

Research Progress of Multidrug Resistance to Cancer Chemotherapy
下载PDF
导出
摘要 肿瘤化疗失败的主要原因是多药耐药(MDR)的产生。肿瘤多药耐药的机制十分广泛,其中以ATP结合盒式结构超家族成员研究较多。文章重点综述目前研究较多的多药耐药机制,并对肿瘤耐药逆转进展作简要介绍。 Multidrug resistance (MDR) of cancer cells is a major cause of failure in chemotherapy. The mechanism of multidrug resistance is vary, while much attention was paid on the expression of ABC (ATP binding cassette) transporter. This paper provides a review on the hotspots of current MDR research. Moreover, the recent progress in the field of MDR reversal is also briefly introduced.
出处 《中国肿瘤》 CAS 2006年第6期382-385,共4页 China Cancer
关键词 肿瘤 多药耐药 药物疗法 neoplasms chemotherapy multidrug resistance
  • 相关文献

参考文献20

  • 1Stouch TR,Gudmundsson O. Progress in understanding the structure-activity relationships of P-glycoprotein [J]. Adv Drug Del Rev,2002,54(3):315-328.
  • 2Fu LW,Liang YJ, Deng LW,et al. Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance [J]. Cancer Chemother Phammcol,2004,53(4): 349-356.
  • 3Tada Y, Wada M, Migita T, et al. Increased expression of multidrug resistance associated proteins in bladder cancer during clinical course and drug resistance to doxorubicin[J]. int J Cancer, 2002,98 (4): 630 -635.
  • 4Hsu CH, Chen CL, Hong RL,et al. Prognostic value of multidrug resistance 1, glutathione-S-Transferase-[pi] and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapy[J]. Oncology, 2002,62(4): 305-312.
  • 5Sharma V, Prior JL, Belinsky MG, et al. Characterization of a sup 67Ga/sup 68Ga radiopharmaceutical for SPECT and PET of MDR1 P-glycoprotein transport activity in vivo:validation in multidrug-resistant tumors and at the blood-brain barrier[J]. J Nucl Med ,2005,46(2):354-364.
  • 6Rittierodt M, Tschemig T, Harada K. Modulation of multidrug-resistance-associated P-glycoprotein in human U-87 MG and HUV-ECC cells with antisense oligodeoxynucleotides to MDR1 mRNA[J]. Pathobiology, 2004,71(3):123-128.
  • 7Borowski E, Bontemps-Gracz MM, Piwkowska A. Strategies for overcoming ABC-transporters-mediated multidrug resistance (MDR) of tumor cells [J]. Acta Biochim Pol,2005,52(3): 609-627.
  • 8Akan I,Akan S,Akca H,et al. Multidrug resistance-associated protein L (MRP1) mediated vincristine resistance: effects of N-acetylcysteine and buthionine sulfoximine [J].Cancer Cell Int,2005,5(1):22-30.
  • 9Laochariyakul P, Ponglikitmongkol M,Mankhetkom S.Functional study of intracellular P-gp-and MRP1-mediated pumping of free cytosolic pirarubicin into acidic organelles in intrinsic resistant SiHa cells[J]. Can J Physiol Pharmacol, 2003,81(8): 790-799.
  • 10Ohsawa M ,Ikura Y,Fukushima H, et al. Immunohistochemical expression of multidrug resistance proteins as a predictor of poor response to chemotherapy and prognosis in patients with nodal diffuse large B-cell lymphoma [J].Oncology, 2005,68(4-6):422-431.

同被引文献63

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部